Stockscreener 앱 받기
0.5497
0.66%
0.0036
시간 외 거래:
.54
-0.0097
-1.76%
Aspire Biopharma Holdings Inc 주식(ASBP)의 최신 뉴스
Aspire Biopharma Holdings, Inc. Building a Base Near Support2025 Retail Activity & Weekly Setup with High ROI Potential - thegnnews.com
Aspire Biopharma Plummets 22.7%: E-Commerce Launch Volatility and Technical Divergence Spark Turbulence - AInvest
Aspire Biopharma Announces Positive Top-Line Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack) - BioSpace
Penny Stocks on the Move: Today’s Top Gainers and Biggest Decliners - AInvest
Aspire Shares Are Trading Higher Monday: What's Going On? - Benzinga
Crude Oil Moves Higher; US Homebuilder Sentiment Declines In August - Benzinga
Aspire Biopharma Holdings shares surge 67.69% intraday after positive clinical trial results for sublingual aspirin product. - AInvest
US Stocks Mixed; Riskified Shares Dip After Q2 Results - Benzinga
Breakthrough Heart Attack Treatment: Sublingual Aspirin Shows Superior Results in Aspire Biopharma Trial - Stock Titan
Aspire Biopharma names new executive chair - MSN
Aspire Biopharma Successfully Launches BUZZ BOMB(TM) Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World - Lubbock Avalanche-Journal
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20 - Miami Herald
Aspire Biopharma to Present at Sidoti Virtual Investor Conference - AInvest
Aspire Biopharma’s BUZZ BOMB Shows Promising Initial Feedback - MSN
Aspire Biopharma Holdings, Inc. SEC 10-Q Report - TradingView
New Pre-Workout BUZZ BOMB Hits Market With Instant-Acting Sublingual Technology - Stock Titan
Aspire Biopharma Holdings, Inc. Announces CEO Transition - Lubbock Avalanche-Journal
Aspire Biopharma Holdings, Inc. Unveils E-commerce Platform, Launches with its BUZZ BOMB Pre-Workout Supplement - Petoskey News-Review
Riding the Waves: A Guide to Investing in ASBP Stock - investchronicle.com
Aspire Biopharma Holdings, Inc. shares rise 4.06% after-hours following Ultragenyx Pharmaceutical Inc. Q2 2025 earnings call. - AInvest
Aspire Biopharma Holdings, Inc. shares rise 2.10% after-hours after unveiling e-commerce platform and launching BUZZ BOMB supplement. - AInvest
What catalysts could drive Aspire Biopharma Holdings Inc. stock higher in 2025Expert Picks Tracker For Beginners - Jammu Links News
Game-Changing Pre-Workout Supplement Delivers Instant Energy Without Water MixingBUZZ BOMB Hits Market - Stock Titan
Why is Aspire Biopharma Holdings Inc. Equity Warrant stock attracting strong analyst attentionDaily Trading Insights With High Returns - Jammu Links News
Aspire Biopharma Announces Leadership Reshuffle Amid Resignations - msn.com
What makes Aspire Biopharma Holdings Inc. Equity Warrant stock price move sharplyPost Market Outlook For Smart Trading - Jammu Links News
Aspire Biopharma Leadership Shakeup: Chairman Takes CEO Role Amid Board Restructuring - Stock Titan
Aspire Biopharma CEO Out After Less Than Two Months, Two Directors Resign - 富途牛牛
ASBP CEO & Audit Chair Resign; Former CEO Returns as Interim | PWUPU SEC FilingForm 8-K - Stock Titan
Uncorrelated Capital Launches with $53M in Funding for Litigation Finance - The Arizona Republic
What catalysts could drive Aspire Biopharma Holdings Inc. Equity Warrant stock higher in 2025Capitalize on fast-moving stock trends - Jammu Links News
How many analysts rate Aspire Biopharma Holdings Inc. as a “Buy”Consistent triple returns - Jammu Links News
Why is Aspire Biopharma Holdings Inc. stock attracting strong analyst attentionSkyrocketing investment returns - Jammu Links News
What is the dividend policy of Aspire Biopharma Holdings Inc. stockConsistent triple-digit returns - Jammu Links News
How does Aspire Biopharma Holdings Inc. compare to its industry peersCapitalize on fast-growing stocks today - Jammu Links News
What is the risk reward ratio of investing in Aspire Biopharma Holdings Inc. stockUnlock powerful trading tools for investors - jammulinksnews.com
Is it the right time to buy Aspire Biopharma Holdings Inc. Equity Warrant stockCapitalize on emerging market trends - Jammu Links News
1.38%
0.27%
자본화:
|
볼륨(24시간):